GlaxoSmithKline gets a lift from Pfizer portfolio

7 November 2019 - Deborah Wilkes

Premium

Worldwide sales at GlaxoSmithKline's (GSK's) Consumer Healthcare business increased by 25% at constant exchange rates in the third quarter of 2019, following consolidation of Pfizer’s Consumer Healthcare products.

Click tags below for more information on topics:

GlaxoSmithKline

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: